findmyKOL
Clinical trialNCT02125279CompletedPhase 4Interventional

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

SponsorGalderma R&DEnrollment54Psoriasis Vulgaris
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to treat pediatric subjects (2 to 16 years and 11 months of age) with mild to moderate plaque psoriasis.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Uz Gent Dermatology Department

    Ghent, Belgium

Canada
  • Lynderm Research Inc.

    Markham, Ontario, Canada

  • Chu Sainte-Justine

    Montreal, Quebec, Canada

Germany
  • Charité Universitätsmedizin Berlin

    Berlin, Germany

  • University Hospital Carl Gustav Carus

    Dresden, Germany

  • Universitäts-Hautklinik Mainz, Johannes Gutenberg-Universität Mainz

    Mainz, Germany

Italy
  • Padova University Hospital

    Padova, Italy

  • University of Parma

    Parma, Italy

United States
  • Johnson Dermatology

    Fort Smith, Arkansas, United States

  • Northwest Arkansas Clinical Trials Center, Pllc

    Rogers, Arkansas, United States

  • Advanced Skincare Surgery & Medcenter

    Burbank, California, United States

  • University of South Florida

    Tampa, Florida, United States

  • Shideler Clinical Research Center

    Carmel, Indiana, United States

  • Dawes Fretzin Clinical Research Group

    Indianapolis, Indiana, United States

  • Montefiore Medical Center

    New York, New York, United States

  • Arlington Research Center for Dermatology

    Arlington, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Calcitriol →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2014
Primary completion
31 May 2018
Completion
31 May 2018
Last update posted
18 Feb 2021
Registered enrollment
54
Registry id
NCT02125279
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.